Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07038785 · ClinicalTrials.gov registry record
Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs
A clinical trial of Breast Cancer, sponsored by SpotitEarly.
- Recruiting
- Registry status
- 1,204
- Enrollment target
- 5
- Study locations
NCT07038785: Recruiting study of Breast Cancer, sponsored by SpotitEarly.
NCT07038785 is a study of Breast Cancer that is actively recruiting participants, run by SpotitEarly. The registered enrollment target is 1,204 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (57% lower). The trial reports 5 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07038785, a study of Breast Cancer, is actively recruiting participants, sponsored by SpotitEarly.
- RECRUITING
- Registry status
- 1,204 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of this study is to find out whether a system that uses trained detection dogs and artificial intelligence (AI) can identify breast cancer from a person's breath. Women who are scheduled to have routine breast cancer screening, such as a mammogram, ultrasound, or a biopsy for a possible cancer, will be invited to take part. Participants will be asked to breathe into a surgical mask to collect a breath sample. The mask will be sent to a special laboratory, where trained dogs and an AI-based system will check the sample for signs of breast cancer. The results from the dogs and AI will be compared to the actual results from the medical screening or biopsy to see how accurate the system is at detecting breast cancer.
Primary Outcome
The test performance will be determined by analysis of the sensitivity and the specificity of the primary endpoint sample set, where sensitivity is the number of participants with a true positive result divided by the number of participants with a positive clinical diagnosis (positive biopsy), and specificity is the number of participants with a true negative result divided by the number of participants with a negative clinical diagnosis.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Breath test
Study Locations (5)
Other
- Rambam Health Care Campus - Haifa
- Sheba Medical Center - Ramat Gan
- Assuta Medical Centers - Tel Aviv
- Tel Aviv Sourasky Medical Center - Tel Aviv
New Jersey
- Hackensack Meridian Health - Totowa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,204 participants |
| Start Date | 2025-07-22 |
| Est. Completion | 2027-06 |
What NCT07038785 shows while recruiting
NCT07038785 is an observational study that tracks outcomes without assigning an intervention. Its 1,204 participants enrollment target places it among the larger protocols in the corpus, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Breath test is the first listed.
NCT07038785 lists 5 locations in 2 states (Other, New Jersey).
Frequently Asked Questions
What is clinical trial NCT07038785 about?
NCT07038785 is a clinical study titled "Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs". The goal of this study is to find out whether a system that uses trained detection dogs and artificial intelligence (AI) can identify breast cancer from a person's breath. Women who are scheduled to have routine breast cancer screening, such as a mammogram, ultrasound, or a biopsy for a possible can...
What is the current status of trial NCT07038785?
This trial is currently recruiting. The enrollment target is 1,204 participants. The study started on 2025-07-22. Estimated completion is 2027-06.
What conditions does trial NCT07038785 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT07038785?
The interventions under investigation include: Breath test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07038785?
This trial is sponsored by SpotitEarly, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07038785 being conducted?
This trial has 5 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07038785's enrollment target sits among peer trials
1,204 105th of 1224 higher than 1,120 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06535854 · 1,205 participants · NA
Prevail Global Study
- NCT07223593 · 1,205 participants · Phase 3
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI